AIDS WEEKLY Plus - November 2002Important note: Information in this article was accurate in November 2002. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

HIV/AIDS Therapy: Antiretroviral therapy restores normal stem cell activity

AIDSWEEKLY Plus; November 4, 2002
Michael Greer, Senior Medical Writer


NewsRx -- Antiretroviral therapy against HIV infection can restore normal hematopoietic stem cell activity, researchers in Italy say.

"Haematological abnormalities frequently occur in patients infected by human immunodeficiency virus-type 1 (HIV-1)," according to Antonella Isgro and colleagues at the University of Rome "La Sapienza" and the San Raffaele Telethon Institute for Gene Therapy in Milan. "Increasing evidence indicates that bone marrow suppression (BM) results from viral infection of accessory cells, with impaired stromal function and alteration of haematopoietic growth factor network."

Highly active antiretroviral therapy (HAART) restores a healthy stromal environment and normalizes hematopoietic cytokine activity, Isgro and coauthors found.

The researchers compared hematopoietic activity in bone marrow (BM) from HIV patients before and after the initiation of HAART. Prior to treatment, bone marrow cells produced lower levels of interleukin (IL)-2 and higher levels of inflammatory cytokines like tumor necrosis factor alpha, macrophage inflammatory protein, and RANTES, they said.

After beginning HAART, cytokine production by bone marrow cells returned to normal levels, study data showed. In addition, while stromal cells showed macrophage-like features and expressed HIV DNA before HAART, antiretroviral treatment restored normal fibroblast-like morphology to these cells and blocked viral DNA expression.

HAART was also associated with the recovery of stem cell clonogenic capability lost after HIV infection (Improvement of interleukin 2 production, clonogenic capability and restoration of stromal cell function in human immunodeficiency virus-type-1 patients after highly active antiretroviral therapy. Br J Haematol 2002 Sep;118(3):864-74.

"Controlling HIV-1 replication may produce amelioration of stem cell activity, and restoration of stromal cell pattern and functions, with increased IL-2 production at BM level," Isgro and colleagues concluded.

The corresponding author for this report is Prof. Fernando Aiuti, Division of Allergy and Clinical Immunology Department of Clinical Medicine, University of Rome "La Sapienza", Viale dell'Universita, 37-00185 Rome, Italy. E-mail: fernando.aiuti@uniroma1.it.

A search at www.NewsRx.net using the search term "AIDS and HIV therapy" yielded 1193 articles in 29 specialized reports.

Key points reported in this study include:

This article was prepared by AIDS Weekly editors from staff and other reports.

021104
AW021103


Copyright © 2002 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.